Characterization of honeybee venom by MALDI-TOF and nanoESI-QqTOF mass spectrometry J Matysiak, CEH Schmelzer, RHH Neubert, ZJ Kokot Journal of Pharmaceutical and Biomedical Analysis 54 (2), 273-278, 2011 | 85 | 2011 |
Urban wastewater analysis as an effective tool for monitoring illegal drugs, including new psychoactive substances, in the Eastern European region AM Sulej-Suchomska, A Klupczynska, P Dereziński, J Matysiak, ... Scientific reports 10 (1), 4885, 2020 | 73 | 2020 |
MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer A Swiatly, A Horala, J Hajduk, J Matysiak, E Nowak-Markwitz, ZJ Kokot Bmc Cancer 17, 1-9, 2017 | 67 | 2017 |
Simultaneous determination of major constituents of honeybee venom by LC-DAD ZJ Kokot, J Matysiak Chromatographia 69, 1401-1405, 2009 | 65 | 2009 |
Challenges in biomarker discovery with MALDI-TOF MS J Hajduk, J Matysiak, ZJ Kokot Clinica Chimica Acta 458, 84-98, 2016 | 63 | 2016 |
Standard methods for Apis mellifera venom research DC de Graaf, MR Brochetto Braga, RMM de Abreu, S Blank, CH Bridts, ... Journal of Apicultural Research 60 (4), 1-31, 2021 | 54 | 2021 |
On the directionality of classically-conditioned glycemic responses J Matysiak, L Green Physiology & behavior 32 (1), 5-9, 1984 | 50 | 1984 |
Understanding ovarian cancer: iTRAQ-based proteomics for biomarker discovery A Swiatly, A Horala, J Matysiak, J Hajduk, E Nowak-Markwitz, ZJ Kokot International Journal of Molecular Sciences 19 (8), 2240, 2018 | 47 | 2018 |
Multielemental analysis of bee pollen, propolis, and royal jelly collected in west-central Poland E Matuszewska, A Klupczynska, K Maciołek, ZJ Kokot, J Matysiak Molecules 26 (9), 2415, 2021 | 46 | 2021 |
Usefulness of amino acid profiling in ovarian cancer screening with special emphasis on their role in cancerogenesis S Plewa, A Horała, P Dereziński, A Klupczynska, E Nowak-Markwitz, ... International journal of molecular sciences 18 (12), 2727, 2017 | 46 | 2017 |
Hyphenated LC–MALDI–ToF/ToF and LC–ESI–QToF approach in proteomic characterization of honeybee venom J Matysiak, J Hajduk, F Mayer, R Hebeler, ZJ Kokot Journal of Pharmaceutical and Biomedical Analysis 121, 69-76, 2016 | 42 | 2016 |
Promising antimicrobial properties of bioactive compounds from different honeybee products M Ratajczak, D Kaminska, E Matuszewska, E Hołderna-Kedzia, J Rogacki, ... Molecules 26 (13), 4007, 2021 | 41 | 2021 |
Serum lipidome screening in patients with stage I non-small cell lung cancer A Klupczynska, S Plewa, M Kasprzyk, W Dyszkiewicz, ZJ Kokot, ... Clinical and Experimental Medicine 19, 505-513, 2019 | 40 | 2019 |
Wide spectrum targeted metabolomics identifies potential ovarian cancer biomarkers S Plewa, A Horała, P Dereziński, E Nowak-Markwitz, J Matysiak, ZJ Kokot Life sciences 222, 235-244, 2019 | 40 | 2019 |
Shotgun proteome analysis of honeybee venom using targeted enrichment strategies J Matysiak, J Hajduk, Ł Pietrzak, CEH Schmelzer, ZJ Kokot Toxicon 90, 255-264, 2014 | 39 | 2014 |
New CZE-DAD method for honeybee venom analysis and standardization of the product ZJ Kokot, J Matysiak, B Urbaniak, P Dereziński Analytical and bioanalytical chemistry 399, 2487-2494, 2011 | 38 | 2011 |
Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients A Bienert, K Kusza, K Wawrzyniak, E Grześkowiak, ZJ Kokot, J Matysiak, ... Journal of pharmacokinetics and pharmacodynamics 37, 289-304, 2010 | 37 | 2010 |
Mass spectrometry-based proteomics techniques and their application in ovarian cancer research A Swiatly, S Plewa, J Matysiak, ZJ Kokot Journal of ovarian research 11, 1-13, 2018 | 36 | 2018 |
Effects of a honeybee sting on the serum free amino acid profile in humans J Matysiak, P Dereziński, A Klupczyńska, J Matysiak, E Kaczmarek, ... PLoS One 9 (7), e103533, 2014 | 32 | 2014 |
Mass spectrometry as a tool for biomarkers searching in gynecological oncology P Banach, W Suchy, P Dereziński, J Matysiak, ZJ Kokot, ... Biomedicine & Pharmacotherapy 92, 836-842, 2017 | 30 | 2017 |